Phase II trial of fludarabine and sandostatin for relapsed low-grade non-Hodgkin's lymphoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fludarabine; Octreotide
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 15 Dec 2016 Biomarkers information updated
- 10 Sep 2005 New trial record.